Here are four facts:
1. Analysts have a $21 12-month price objective on Surgery Partners’ shares.
2. On Oct. 12, 2016, Zacks lowered Surgery Partners’ shares from a “hold” to a “sell” rating.
3. On Nov. 10, 2016, Jeffries Group restated its “buy” rating on the company’s shares.
4. Surgery Partners has a market cap. of $682.54 million.
More articles on surgery centers:
Maintaining infection control compliance at ASCs: 4 key strategies to yield success
Parkview Medical Center unveils multimillion-dollar expansion plans featuring surgery center: 4 points
Hennepin County Medical Center slashes workforce by 4% to boost budget for $200M ASC — 4 highlights
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
